- Home
- Publications
- Publication Search
- Publication Details
Title
Gene Therapy for Parkinson's Disease
Authors
Keywords
-
Journal
Parkinsons Disease
Volume 2012, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2012-03-26
DOI
10.1155/2012/757305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Of Monkeys and Men: Analysis of the Phase 2 Double-Blind, Sham-Surgery Controlled, Randomized Trial of AAV2-Neurturin Gene Therapy for Parkinson’s Disease
- (2011) Daniel E. Huddleston et al. Current Neurology and Neuroscience Reports
- Parkin-Mediated Protection of Dopaminergic Neurons in a Chronic MPTP-Minipump Mouse Model of Parkinson Disease
- (2011) Toru Yasuda et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Efficient Allele-Specific Targeting of LRRK2 R1441 Mutations Mediated by RNAi
- (2011) Laura de Yñigo-Mojado et al. PLoS One
- Adenovirus
- (2011) Joseph Lynch et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat
- (2010) Helen L. Fitzsimons et al. JOURNAL OF GENE MEDICINE
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
- (2010) Piotr Hadaczek et al. MOLECULAR THERAPY
- Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains
- (2010) Raymond T. Bartus et al. MOVEMENT DISORDERS
- Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
- (2010) Jaime N. Guzman et al. NATURE
- AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease
- (2009) Y-Q Xue et al. GENE THERAPY
- Aromatic l-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla
- (2009) Kunio Kitahama et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles
- (2009) Rongqin Huang et al. JOURNAL OF GENE MEDICINE
- Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates
- (2009) Hemraj B Dodiya et al. MOLECULAR THERAPY
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE
- (2009) Christopher D. Herzog et al. NEUROSURGERY
- Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
- (2009) B. Jarraya et al. Science Translational Medicine
- Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles
- (2008) Haiyan Cao et al. BMC NEUROSCIENCE
- Clinical gene therapy using recombinant adeno-associated virus vectors
- (2008) C Mueller et al. GENE THERAPY
- Non-dopaminergic treatments in development for Parkinson's disease
- (2008) Susan H Fox et al. LANCET NEUROLOGY
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Transgene Expression, Bioactivity, and Safety of CERE-120 (AAV2-Neurturin) Following Delivery to the Monkey Striatum
- (2008) Christopher D Herzog et al. MOLECULAR THERAPY
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- Viral vectors for in vivo gene transfer in Parkinson's disease: Properties and clinical grade production
- (2007) Ronald J. Mandel et al. EXPERIMENTAL NEUROLOGY
- Design of clinical trials of gene therapy in Parkinson disease
- (2007) Travis B. Lewis et al. EXPERIMENTAL NEUROLOGY
- Regulatable promoters and gene therapy for Parkinson's disease: Is the only thing to fear, fear itself?
- (2007) Jeffrey H. Kordower et al. EXPERIMENTAL NEUROLOGY
- Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter
- (2007) Chun-Fang Xia et al. JOURNAL OF GENE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started